Glenmark Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS INC, and what generic and branded alternatives to GLENMARK PHARMS INC drugs are available?
GLENMARK PHARMS INC has nineteen approved drugs.
Summary for Glenmark Pharms Inc
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 17 |
| NDAs: | 19 |
Drugs and US Patents for Glenmark Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Inc | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 201587-001 | Jan 24, 2013 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Inc | MOMETASONE FUROATE | mometasone furoate | CREAM;TOPICAL | 078541-001 | May 28, 2008 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Inc | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651-003 | Jan 30, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Inc | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 201994-001 | Mar 6, 2012 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
